recent
evid
suggest
mutat
spike
protein
gene
felin
coronaviru
fcov
result
amino
acid
chang
methionin
leucin
posit
may
associ
felin
infecti
periton
fip
tissu
faecal
sampl
collect
post
mortem
cat
diagnos
without
fip
subject
rna
extract
quantit
reversetranscriptas
polymeras
chain
reaction
qrtpcr
detect
fcov
rna
cat
fip
tissu
faecal
sampl
pcrposit
oppos
tissu
faecal
sampl
cat
without
fip
rel
fcov
copi
number
significantli
higher
cat
fip
tissu
p
faec
p
pcrposit
sampl
underw
pyrosequenc
encompass
posit
fcov
spike
protein
identifi
methionin
codon
posit
consist
shed
enter
form
fcov
faecal
sampl
cat
fip
sampl
cat
without
fip
contrast
tissu
sampl
cat
fip
cat
without
fip
leucin
codon
posit
consist
system
form
fcov
result
suggest
methionin
leucin
substitut
posit
fcov
spike
protein
indic
system
spread
fcov
intestin
rather
viru
potenti
caus
fip
felin
coronaviru
fcov
infect
ubiquit
domest
cat
particularli
multicat
household
anim
may
infect
major
fcov
infect
asymptomat
associ
mild
enter
diseas
howev
approxim
infect
cat
develop
invari
fatal
diseas
felin
infecti
periton
fip
one
import
question
fcov
research
fcovinfect
cat
develop
fip
wherea
other
remain
healthi
one
current
model
fip
pathogenesi
propos
cat
infect
fcov
faecalor
rout
subsequ
viru
mutat
virul
form
form
enhanc
tropism
monocytesmacrophag
vitro
studi
suggest
reflect
sustain
replic
subsequ
activ
monocyt
activ
monocyt
carri
viru
blood
result
complex
interact
endotheli
cell
induc
granulomat
phlebiti
pathogen
hallmark
fip
age
breed
gender
reproduct
statu
immun
respons
individu
cat
also
influenc
develop
fip
current
intens
interest
determin
mutat
alter
virul
fcov
recent
paper
publish
chang
et
al
deriv
full
genom
sequenc
data
collect
fcov
obtain
faec
healthi
cat
tissu
cat
diagnos
fip
provid
evid
associ
fcov
virul
amino
acid
substitut
methionin
leucin
posit
within
put
fusion
peptid
fcov
spike
protein
specif
author
conclud
substitut
distinguish
fip
nonfip
associ
fcov
case
second
substitut
two
amino
acid
downstream
serin
alanin
posit
distinguish
fip
nonfip
associ
fcov
protein
fusion
peptid
critic
element
fusion
viral
cellular
membran
viru
entri
reason
think
amino
acid
substitut
within
peptid
may
alter
tropism
viru
addit
studi
licitra
et
al
shown
possibl
distinguish
fcov
anim
without
fip
basi
one
substitut
amino
acid
sequenc
compris
furin
cleavag
motif
within
protein
furin
cleavag
site
consensu
motif
rxkrr
r
basic
arginin
residu
x
residu
k
basic
lysin
residu
delin
border
receptorbind
fusion
domain
protein
distinct
substitut
site
describ
mutat
site
propos
alter
proteolyt
cleavag
protein
modifi
protein
fusogen
properti
may
relat
tropism
viru
final
pedersen
et
al
conclud
truncat
nontrunc
mutat
gene
occur
signific
proport
fcov
associ
fip
chang
et
al
suggest
function
protein
express
crucial
fcov
replic
gut
dispens
system
replic
howev
also
exclud
possibl
loss
alter
protein
may
enhanc
fit
viru
monocytemacrophag
environ
past
year
univers
bristol
collect
larg
number
postmortem
tissu
faecal
sampl
cohort
thoroughli
examin
cat
includ
cat
definit
diagnosi
fip
confirm
presenc
typic
histolog
fip
lesion
immunohistochemistri
ihc
demonstr
fcov
antigen
within
macrophag
cat
diseas
fip
complet
lack
histolog
chang
consist
fip
importantli
longterm
studi
enabl
faecal
tissu
sampl
collect
fcovinfect
cat
without
fip
allow
compar
sampl
natur
infect
cat
examin
sampl
screen
fcov
rna
quantit
revers
transcriptasepolymeras
chain
reaction
qrtpcr
posit
assess
substitut
pyrosequenc
postmortem
tissu
sampl
faec
whenev
possibl
collect
cat
euthan
suspect
fip
due
diseas
fip
definit
diagnos
exclud
histopatholog
case
fip
demonstr
fcov
antigen
fip
lesion
ihc
tissu
cat
without
fip
also
test
ihc
presenc
viral
antigen
tissu
sampl
collect
rnalat
life
technolog
within
h
death
subsequ
molecular
analysi
tissu
sampl
left
rnalat
h
room
temperatur
rnalat
discard
tissu
sampl
store
faecal
sampl
store
use
sampl
collect
neutralbuff
formalin
histolog
ihc
tissu
collect
compris
primarili
mesenter
lymph
node
liver
kidney
spleen
omentum
tissu
eg
intestin
brain
lung
pericardium
pancrea
lymph
node
includ
base
gross
patholog
find
report
clinic
sign
formalinfix
tissu
sampl
subject
standard
process
histopatholog
embed
paraffin
wax
section
prepar
stain
haematoxylineosin
section
examin
boardcertifi
veterinari
pathologist
mjd
univers
bristol
histopatholog
chang
select
wax
block
sent
veterinari
laboratori
servic
univers
liverpool
ihc
analysi
previous
describ
cat
assign
fip
group
need
histopatholog
chang
consist
fip
fcov
antigen
demonstr
within
macrophag
lesion
cat
assign
nonfip
group
histopatholog
chang
consist
fip
need
complet
absent
fcov
antigen
within
macrophag
need
absent
tissu
individu
tissu
sampl
posit
qrtpcr
result
lesion
consist
fip
histopatholog
use
pyrosequenc
faecal
sampl
classifi
basi
diagnosi
attribut
cat
sampl
origin
total
rna
extract
mg
tissu
mg
faec
nucleospin
rna
ii
kit
machereynagel
use
method
base
previou
work
dye
siddel
revers
transcript
done
use
mj
mini
gradient
thermal
cycler
improm
ii
revers
transcriptas
promega
nine
microlitr
total
rna
solut
combin
improm
ii
reaction
buffer
mm
mgcl
dntp
mm
random
hexam
improm
ii
revers
transcriptas
reaction
made
total
volum
rnasefre
water
follow
thermal
profil
use
min
min
min
hold
result
cdna
ad
rnasefre
water
store
randomli
select
sampl
check
inhibit
rt
reaction
use
rna
intern
amplif
control
inhibit
detect
result
shown
qpcr
done
agil
qpcr
system
agil
technolog
qpcr
master
mix
made
reaction
gotaq
master
mix
promega
forward
revers
primer
tabl
taqman
probe
tabl
mm
mgcl
made
rnasefre
water
primer
probe
produc
metabion
metabion
intern
describ
previous
dye
et
al
onetenth
randomli
prime
cdna
ad
pcr
master
mix
reaction
plate
heat
seal
follow
thermal
profil
use
min
cycl
fluoresc
detect
nm
extens
phase
felin
cov
cdna
use
posit
control
rnasefre
water
neg
control
reaction
fail
reach
threshold
cycl
ct
valu
cycl
deem
neg
ct
valu
assign
rel
copi
number
follow
equat
take
account
effici
qrtpcr
assay
use
calcul
rel
copi
number
qrtpcr
posit
sampl
valu
sampl
posit
fcov
qrtpcr
underw
convent
pcr
amplifi
basepair
dna
fragment
encompass
posit
protein
gene
pcr
done
use
mj
mini
gradient
thermal
cycler
briefli
reaction
pcr
mix
made
includ
gotaq
master
mix
forward
revers
primer
tabl
randomli
prime
cdna
reaction
product
water
volum
follow
thermal
profil
use
min
cycl
held
pcr
product
use
pyrosequenc
reaction
store
requir
sampl
fail
produc
definit
sequenc
data
pyrosequenc
follow
repeat
amplif
use
pcr
protocol
cycl
amplif
singl
strand
sequenc
templat
produc
bind
biotinyl
pcr
product
streptavidinco
sepharos
bead
fisher
follow
chemic
denatur
neutralis
sampl
follow
mix
prepar
streptavidin
bead
pyromark
bind
buffer
qiagen
ph
contain
mm
trishcl
nacl
mm
edta
tween
made
water
bead
mixtur
ad
pcr
product
shaken
rpm
min
sequenc
primer
mix
contain
sequenc
primer
tabl
pyromark
anneal
buffer
qiagen
mm
trisoac
mm
mgoac
ph
sampl
control
oligonucleotid
selfsequenc
oligonucleotid
mix
contain
oligonucleotid
anneal
buffer
twenti
five
microlitr
sequenc
primer
mix
ad
appropri
well
pyrosequenc
plate
control
oligonucleotid
ad
one
well
plate
place
pyrosequenc
workstat
pyrosequenc
workstat
prepar
tray
contain
wash
buffer
mm
trisoac
ph
denatur
buffer
naoh
ethanol
distil
water
streptavidin
bead
bound
pcr
product
taken
use
vacuum
pump
pyrosequenc
bead
collector
bead
collector
place
ethanol
denatur
buffer
wash
buffer
turn
vacuum
bead
collector
place
pyrosequenc
plate
agit
dislodg
bead
pyrosequenc
plate
heat
plate
holder
min
place
pyromark
qiagen
left
cool
min
plate
cool
pyrosequenc
cartridg
prepar
pyromark
gold
enzym
substrat
dntp
qiagen
ad
appropri
well
cartridg
volum
outlin
pyromark
softwar
experiment
set
dispens
order
nucleotid
defin
cgctcatg
cartridg
place
pyromark
instrument
protocol
run
primer
use
pyrosequenc
assay
design
use
combin
pyromark
assay
design
softwar
qiagen
primer
softwar
mfold
made
eurofin
mwg
operon
tabl
primer
posit
base
use
chang
et
al
number
accord
fcov
genom
genbank
degeneraci
ad
primer
locat
primer
optimis
base
upon
sequenc
align
compris
avail
type
fcov
genom
data
shown
convent
pcr
amplifi
basepair
dna
fragment
encompass
posit
protein
gene
carri
describ
see
pyrosequenc
method
sampl
show
substitut
pyrosequenc
assay
pcr
primer
use
sequenc
primer
standard
sanger
sequenc
protocol
eurofin
mwg
operon
fcov
rel
copi
number
enter
databas
excel
microsoft
export
ibm
spss
statist
softwar
version
data
set
evalu
normal
distribut
use
kolmogorovsmirnov
ks
test
nonnorm
distribut
data
describ
median
rang
minimum
maximum
valu
data
evalu
fcov
rel
copi
number
tissu
faecal
sampl
cat
without
fip
analys
use
multilevel
model
approach
mlwin
account
repeat
measur
within
cat
nonparametr
mannwhitney
u
test
conclus
drawn
analys
full
agreement
simpler
mannwhitney
u
test
analysi
present
rel
copi
number
compar
fip
nonfip
sampl
tissu
faecal
sampl
combin
faecal
sampl
tissu
sampl
signific
assign
level
p
histor
sampl
collect
full
inform
consent
owner
sampl
could
use
research
purpos
project
approv
ethic
review
univers
bristol
anim
welfar
ethic
review
board
total
sampl
analys
full
detail
sampl
result
shown
tabl
cat
fip
diagnosi
confirm
histopatholog
demonstr
fcov
antigen
within
macrophag
fip
lesion
ihc
cat
without
fip
diagnosi
made
histolog
neoplasia
eg
lymphoma
astrocytoma
chemodectoma
biliari
cystadenoma
inflammatori
process
eg
chronic
lymphoplasmacyt
infiltr
unknown
aetiolog
liver
kidney
bronchopneumonia
predomin
total
faecal
sampl
analys
fcov
qrtpcr
posit
compris
faecal
sampl
cat
fip
faecal
sampl
cat
without
fip
tabl
total
tissu
sampl
analys
fcov
qrtpcr
posit
compris
tissu
sampl
cat
fip
tissu
sampl
cat
without
fip
tabl
rel
fcov
rna
copi
number
normal
distribut
p
rel
copi
number
pool
faecal
tissu
sampl
fip
group
median
rang
significantli
higher
u
p
nonfip
group
tissu
sampl
consid
rel
copi
number
fip
group
also
significantli
higher
nonfip
group
u
p
final
analysi
faecal
sampl
alon
show
rel
copi
number
fip
group
significantli
higher
nonfip
group
u
p
faecal
tissu
sampl
posit
qrtpcr
result
subject
pyrosequenc
assay
faecal
sampl
success
sequenc
obtain
use
cycl
pyrosequenc
assay
wherea
requir
cycl
assay
tissu
sampl
success
sequenc
obtain
use
cycl
pyrosequenc
assay
wherea
requir
cycl
pcr
faecal
sampl
posit
qrtpcr
methionin
aug
codon
alon
found
posit
tabl
figur
sampl
leucin
codon
uug
alon
found
posit
tabl
figur
addit
sampl
cat
faec
show
mix
popul
rna
code
either
methionin
aug
leucin
cug
posit
tabl
figur
importantli
methionin
leucin
codon
identifi
faecal
rna
sampl
cat
without
fip
tabl
specif
methionin
codon
identifi
sampl
fip
cat
leucin
codon
identifi
sampl
fip
cat
overal
methionin
codon
found
major
faecal
sampl
cat
fip
signific
number
leucin
codon
similarli
methionin
codon
identifi
sampl
cat
without
fip
includ
one
mix
infect
leucin
codon
identifi
sampl
cat
without
fip
mix
infect
overal
methionin
codon
found
faecal
sampl
cat
without
fip
sampl
cat
leucin
codon
also
methionin
mix
infect
tissu
sampl
posit
qrtpcr
leucin
codon
uug
cug
alon
found
posit
tabl
figur
remain
tissu
sampl
methionin
codon
aug
found
posit
tabl
tissu
type
defin
superscript
omentum
b
liver
c
kidney
lung
e
stomach
f
lymph
node
g
cerebrum
h
abdomin
lymph
node
heart
j
spleen
k
colon
l
mesenter
lymph
node
brain
n
mesenteri
pleura
p
pericardium
q
medulla
r
pon
small
intestin
intestin
amino
acid
code
posit
protein
fcov
rna
tissu
sampl
without
substitut
defin
superscript
ucu
ser
gcu
ala
figur
mix
infect
found
tissu
sampl
importantli
leucin
methionin
codon
identifi
rna
tissu
sampl
cat
without
fip
tabl
specif
leucin
codon
identifi
sampl
fip
cat
methionin
codon
identifi
sampl
fip
cat
overal
leucin
codon
found
major
fip
tissu
sampl
signific
number
methionin
codon
similarli
leucin
codon
identifi
sampl
cat
without
fip
methionin
codon
identifi
sampl
cat
without
fip
overal
leucin
codon
found
major
tissu
sampl
cat
without
fip
minor
methionin
codon
one
specif
case
cat
note
sampl
one
tissu
spleen
contain
leucin
codon
wherea
sampl
three
tissu
liver
lung
mesenter
lymph
node
contain
methionin
codon
convent
rtpcr
amplif
product
rna
tissu
sampl
contain
substitut
cat
analys
sanger
sequenc
substitut
one
sampl
cat
pleura
show
alanin
codon
posit
remain
four
sampl
cat
three
cat
show
serin
codon
posit
tabl
import
find
studi
substitut
fcov
protein
correl
fip
diseas
phenotyp
propos
chang
et
al
reach
conclus
two
observ
first
although
leucin
codon
found
major
tissu
sampl
fip
lesion
leucin
codon
also
found
major
nonfip
tissu
sampl
second
signific
number
fip
tissu
sampl
methionin
codon
posit
tissu
sampl
natur
fcov
infect
cat
without
fip
previous
evalu
provid
import
insight
fcov
infect
absenc
fip
believ
substitut
like
marker
system
fcov
infect
oppos
marker
fip
develop
diseas
tissu
sampl
collect
postmortem
exclud
possibl
cat
without
fip
sampl
cat
leucin
codon
posit
would
gone
develop
fip
euthan
due
reason
howev
histopatholog
chang
consist
fip
absent
cat
ihc
identifi
fcov
antigen
find
major
tissu
sampl
cat
without
fip
leucin
codon
posit
challeng
idea
system
spread
fcov
import
step
develop
fip
inde
latter
support
find
studi
sinc
fcov
rna
found
far
greater
proport
tissu
sampl
fip
lesion
tissu
sampl
cat
without
fip
sampl
qrtpcr
posit
significantli
higher
fcov
rel
copi
number
found
fip
sampl
found
previou
studi
natur
infect
cat
howev
sampl
studi
took
place
postmortem
could
also
argu
elev
fcov
level
fip
tissu
consequ
massiv
immunolog
dysregul
result
diseas
rather
contribut
factor
toward
develop
diseas
anoth
viewpoint
low
level
fcov
rna
tissu
cat
without
fip
result
fcov
infect
fulli
differenti
macrophag
monocyt
among
tissuespecif
macrophag
view
support
result
ihc
detect
method
low
sensit
detect
fcov
antigen
anywher
pcrposit
tissu
cat
without
fip
provid
evid
low
level
viral
infect
either
tissu
macrophag
persist
infect
anim
monocyt
vessel
respect
organ
time
sampl
find
also
accord
recent
vivo
vitro
studi
show
virul
form
fcov
effect
sustain
replic
monocyt
substitut
protein
substitut
propos
chang
et
al
correl
fip
diseas
phenotyp
also
show
second
substitut
distinguish
fip
nonfip
associ
fcov
confirm
result
far
rna
obtain
one
five
tissu
sampl
show
substitut
show
substitut
believ
propos
chang
et
al
chang
substitut
potenti
other
could
repres
class
mutat
influenc
fusogen
activ
fcov
protein
deserv
particular
attent
regard
pathogenesi
fip
noteworthi
substitut
identifi
licitra
et
al
propos
distinguish
fcov
anim
without
fip
also
suggest
effect
upon
fusogen
activ
protein
regard
faecal
sampl
studi
found
unexpectedli
high
percentag
faecal
sampl
cat
fip
fcov
qrtpcr
posit
rel
copi
number
significantli
higher
faecal
sampl
cat
without
fip
moreov
major
fcov
rna
sequenc
faecal
sampl
cat
fip
methionin
codon
posit
fcov
protein
gene
suggest
anim
shed
enter
form
viru
seem
reason
suggest
cat
infect
enter
system
virul
form
fcov
whether
one
form
deriv
follow
singl
infect
whether
cat
infect
twice
differ
fcov
determin
propos
sever
immun
dysregul
cat
endstag
fip
might
creat
opportun
superinfect
enter
fcov
circul
surround
carrier
interestingli
smaller
signific
proport
faecal
sampl
cat
fip
provid
fcov
rna
sampl
encod
leucin
posit
current
model
fip
pathogenesi
propos
enter
form
viru
mutat
virul
form
gener
longer
horizont
transmit
via
faec
view
challeng
current
result
also
suggest
system
form
viru
found
faec
fip
cat
howev
accept
mean
excret
viru
necessarili
abl
infect
cat
enter
rout
recent
shown
experiment
studi
research
necessari
resolv
issu
contrast
pattern
shown
analysi
faecal
sampl
cat
fip
analysi
faecal
sampl
cat
without
fip
seem
straightforward
nonfip
faecal
sampl
fcov
qrtpcr
posit
encod
methionin
posit
indic
infect
enter
form
viru
also
found
studi
shed
proport
cat
without
fip
unexpect
interest
faecal
sampl
cat
without
fip
cat
show
mix
popul
rna
encod
either
methionin
leucin
posit
evid
fcov
rna
singl
tissu
sampl
taken
cat
therefor
one
interpret
could
substitut
faecal
sampl
rel
recent
event
viru
yet
spread
system
howev
interpret
consid
tent
observ
exampl
neg
qrtpcr
result
tissu
sampl
cat
clearli
fcov
infect
due
fip
group
cat
liver
cat
liver
histopatholog
result
ihc
two
liver
sampl
show
chang
consist
fip
neg
qrtpcr
result
like
arisen
due
absenc
fcov
particular
sampl
taken
molecular
analysi
variabl
distribut
fcov
affect
tissu
report
studi
importantli
also
demonstr
pcrbase
pyrosequenc
approach
rapid
accur
method
identifi
singl
nucleotid
differ
specif
posit
within
dna
fragment
case
viral
genom
howev
limit
sampl
requir
rather
cycl
pcr
amplif
gener
adequ
amount
dna
sequenc
especi
true
pcr
product
gener
sampl
contain
low
amount
viral
rna
eg
tissu
sampl
cat
without
fip
also
sever
sampl
despit
contain
quantiti
viral
rna
measur
qrtpcr
produc
suffici
pcr
product
pyrosequenc
even
amplif
cycl
sampl
exclud
result
contribut
addit
sequenc
data
studi
howev
one
explan
may
despit
degeneraci
primer
use
differ
viral
primer
bind
site
may
preclud
effici
amplif
sampl
summari
use
pyrosequenc
assay
determin
distribut
specif
substitut
protein
fcov
rna
obtain
larg
number
postmortem
tissu
faecal
sampl
cat
without
fip
addit
sanger
sequenc
use
determin
whether
substitut
present
tissu
sampl
contain
substitut
repres
first
studi
compar
similar
sampl
cat
without
fip
regard
viral
phenotyp
result
contribut
better
understand
fcov
genom
mutat
may
may
use
marker
viru
phenotyp
result
also
make
clear
relationship
viral
genotyp
develop
fip
complex
current
use
approach
involv
deep
sequenc
complet
fcov
genom
clinic
sampl
order
throw
light
relationship
